New Proteomics Platform Boosted Single-Cell Throughput
A novel nanoLC-MS system now enables the analysis of 288 single cells per day through optimized peptide separation.
Updated on Sept. 23, 2026 in Biotech
Researchers have developed a multicolumn nanoLC-MS platform that dramatically increases throughput for single-cell proteomics. This research-stage system maintains stable performance over 1,200 consecutive injections, resolving constraints found in conventional workflows.
Why it matters
Conventional proteomics workflows have been limited by long gradient times and low throughput, hindering large-scale cellular analysis. By enabling high-throughput identification, this platform accelerates the speed at which researchers can map proteomic landscapes across thousands of individual samples.
The system achieves 5-minute separation windows at 100 nL/min flow rates, using 250 pg digest injections to identify an average of 4,000 proteins per HeLa cell. It successfully maintains stable peptide separation over 1,200 consecutive injections.
The players
HeLa
An immortal cell line widely used in biological research for protein identification and cellular analysis.
RAW264.7
A macrophage cell line frequently utilized in immunology studies to observe inflammatory responses.
The details
The platform utilizes a multicolumn nanoLC-MS (nanoflow liquid chromatography-mass spectrometry — a technique for separating and identifying complex protein mixtures) architecture to achieve 100% duty cycles. By staggering parallel columns to eliminate idle time during peptide separation, the researchers bypassed the long gradient requirements that typically bottleneck single-cell proteomics. The study validated this setup across more than 4,000 samples, including 783 LPS-treated RAW264.7 macrophages.
Timeline
September 23, 2026: The research findings were published.
The Tech Race
This development marks a significant departure from the throughput limitations inherent in conventional nanoLC-MS workflows. It pushes the field closer to high-coverage, single-cell protein profiling at a scale previously reserved for transcriptomics.
This research-stage technology primarily affects high-throughput proteomics labs that require deep protein coverage across thousands of individual cells. For the broader research community, it signals a potential shift in the cost and time requirements for large-scale clinical protein profiling.
The takeaway
The study demonstrates that multicolumn architectures can solve the classic trade-off between throughput and protein identification depth in single-cell analysis. Interested researchers should monitor follow-up studies regarding the integration of this platform into automated diagnostic workflows.
Further reading
For broader trends in protein analysis, explore the Biotech section.
Source note: This article includes information reported by Nature.
